|
|
Volumn 3, Issue 11, 2012, Pages 1260-1261
|
|
Toll-like receptor 2: Therapeutic target for gastric carcinogenesis
a
b
c
d
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
EPIRUBICIN;
FLUOROURACIL;
MYELOID DIFFERENTIATION FACTOR 88;
OPN 301;
SMALL INTERFERING RNA;
TOLL LIKE RECEPTOR 2;
UNCLASSIFIED DRUG;
ADVANCED CANCER;
ANTINEOPLASTIC ACTIVITY;
CANCER INHIBITION;
CANCER RECURRENCE;
CANCER SIZE;
CANCER SURVIVAL;
CHRONIC INFLAMMATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
EDITORIAL;
GENE AMPLIFICATION;
GENE OVEREXPRESSION;
GENE TARGETING;
HUMAN;
INTRACELLULAR SIGNALING;
NONHUMAN;
OVERALL SURVIVAL;
SOMATIC MUTATION;
STOMACH CANCER;
STOMACH CARCINOGENESIS;
STRATEGIC PLANNING;
SURVIVAL RATE;
TOLL LIKE RECEPTOR 2 GENE;
UPREGULATION;
|
|
EID: 84872788892
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.735 Document Type: Editorial |
|
Times cited : (6)
|
|
References (8)
|
